Richard Peters

Richard Peters was the founder of X4 Pharmaceuticals, Inc. (2014), X4 Pharmaceuticals, Inc. (2010), MedNav, Inc. (1997) where the title held was Chief Executive Officer, and PIC Therapeutics, Inc. (2016) where the title held was Director.
Dr. Peters is also the founder of Tellbio, Inc. Dr. Peters is currently the President, Chief Executive Officer & Director at Yumanity, Inc., Chairman at Pharming Group NV since 2023, and Chairman at Aprea Therapeutics, Inc. since 2020.
Former positions include President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc. (2017-2019), President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc. (2020-2022), Director-Medical Affairs at Amgen, Inc. (2003-2006), Senior Director at Onyx Pharmaceuticals, Inc. (2006-2008), Lead Independent Director at Kineta, Inc. (2022-2025), and Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
(2008-2017).
Education includes a doctorate from The Medical University of South Carolina and an undergraduate degree from College of Charleston.